Search hospitals > Texas > San Antonio
Children's Hospital of San Antonio
Claim this profileSan Antonio, Texas 78207
Global Leader in Tumors
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Recurrence
Conducts research for Brain Tumor
122 reported clinical trials
1 medical researcher
Summary
Children's Hospital of San Antonio is a medical facility located in San Antonio, Texas. This center is recognized for care of Tumors, Lymphoma, Leukemia, Recurrence, Brain Tumor and other specialties. Children's Hospital of San Antonio is involved with conducting 122 clinical trials across 309 conditions. There are 1 research doctors associated with this hospital, such as Timothy C. Griffin.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Lymphoma
Global LeaderStage IV
Stage II
Stage III
Top PIs
Clinical Trials running at Children's Hospital of San Antonio
Brain Tumor
Langerhans Cell Histiocytosis
Germ Cell Tumors
Osteosarcoma
Acute Myeloid Leukemia
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Astrocytoma
Neuroblastoma
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital of San Antonio?
Children's Hospital of San Antonio is a medical facility located in San Antonio, Texas. This center is recognized for care of Tumors, Lymphoma, Leukemia, Recurrence, Brain Tumor and other specialties. Children's Hospital of San Antonio is involved with conducting 122 clinical trials across 309 conditions. There are 1 research doctors associated with this hospital, such as Timothy C. Griffin.